Revenue: The sum of all revenue fields included for a company's operating activities.
Verona Pharma PLC American Depositary Share (VRNA) had Revenue of $42.28M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$42.28M |
$-173.42M |
|
$2.58M |
|
$39.70M |
|
$196.91M |
|
$-154.63M |
|
$-8.50M |
|
$-163.13M |
|
$-163.13M |
|
$-173.42M |
|
$-173.42M |
|
$-173.42M |
|
$-173.42M |
|
$-154.63M |
|
$-152.26M |
|
81.54M |
|
81.54M |
|
$-2.13 |
|
$-2.13 |
|
| Balance Sheet Financials | |
$453.57M |
|
$1.10M |
|
$20.67M |
|
$474.24M |
|
$42.68M |
|
$120.34M |
|
$227.00M |
|
$269.68M |
|
$204.56M |
|
$204.01M |
|
$204.56M |
|
84.63M |
|
| Cash Flow Statement Financials | |
$-122.20M |
|
$-0.58M |
|
$250.78M |
|
$271.77M |
|
$399.76M |
|
$127.98M |
|
$41.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.63 |
|
-- |
|
-- |
|
0.37 |
|
0.59 |
|
93.89% |
|
-365.73% |
|
-365.73% |
|
-360.14% |
|
-385.84% |
|
-410.18% |
|
$-122.78M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.41 |
|
1.13 |
|
321.65 |
|
-84.78% |
|
-85.00% |
|
-36.57% |
|
-53.38% |
|
$2.42 |
|
$-1.51 |
|
$-1.50 |
|